Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CES2 | O00748 | 4/20 | 0.44 |
| ▸ | CES1 | P23141 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL600051 | 0.87 | TDP1 (0.52) | TDP1L3MBTL1CYP3A4MAPTTSHR | |
| SCHEMBL2853917 | 0.87 | TDP1 (0.52) | TDP1L3MBTL1CYP3A4MAPTTSHR | |
| SCHEMBL7105558 | 0.87 | TDP1 (0.54) | TDP1L3MBTL1CYP3A4MAPTTSHR | |
| SCHEMBL29251170 | 0.85 | TDP1 (0.50) | TDP1L3MBTL1CYP3A4MAPTTSHR | |
| SCHEMBL11607787 | 0.85 | TDP1 (0.50) | TDP1L3MBTL1CYP3A4MAPTTSHR | |
| SCHEMBL27899184 | 0.85 | TDP1 (0.50) | TDP1L3MBTL1CYP3A4MAPTTSHR | |
| SCHEMBL31412096 | 0.85 | TDP1 (0.50) | TDP1L3MBTL1CYP3A4MAPTTSHR | |
| SCHEMBL6120810 | 0.83 | TDP1 (0.48) | TDP1L3MBTL1CYP3A4MAPTTSHR | |
| Benzil SCHEMBL28010897 | 0.82 | CES2 (0.58) | TDP1L3MBTL1CYP3A4MAPTALDH1A1 | |
| SCHEMBL6920855 | 0.79 | PGR (0.53) | TDP1L3MBTL1CYP3A4MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170152464-A1 | Composition Comprising Microcapsules | PROCTER & GAMBLE (US) | 2017-06-01 | — | — | US | claimed |
| CN-102171325-B | Composition comprising microcapsules | PROCTER & GAMBLE | 2014-06-25 | — | — | CN | claimed |
| US-8664174-B2 | Composition comprising microcapsules | THE PROCTER & GAMBLE COMPANY (US) | 2014-03-04 | — | — | US | claimed |
| EP-2169042-B1 | Composition comprising microcapsules | PROCTER & GAMBLE (US) | 2012-04-18 | — | — | EP | claimed |
| CN-102171325-A | Composition comprising microcapsules | PROCTER & GAMBLE | 2011-08-31 | — | — | CN | claimed |
| WO-2010039485-A1 | COMPOSITION COMPRISING MICROCAPSULES | THE PROCTER & GAMBLE COMPANY (US) | 2010-04-08 | — | — | WO | claimed |
| US-20100080831-A1 | Composition Comprising Microcapsules | THE PROCTER & GAMBLE COMPANY | 2010-04-01 | — | — | US | claimed |
| EP-2169042-A1 | Composition comprising microcapsules | The Procter and Gamble Company (US) | 2010-03-31 | — | — | EP | claimed |
| US-12558297-B2 | Consumer product with controlled release, biodegradable core-shell microcapsule compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2026-02-24 | — | — | US | disclosed |
| EP-3746533-B1 | LIQUID FABRIC ENHANCERS COMPRISING BRANCHED POLYESTER MOLECULES | PROCTER & GAMBLE (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-3623527-B1 | FABRIC CARE COMPOSITION COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS | PROCTER & GAMBLE (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-3802661-B1 | LIQUID FABRIC ENHANCERS COMPRISING BRANCHED POLYESTER MOLECULES | PROCTER & GAMBLE (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-2845896-B1 | A process of using a consumer product for treating fabric | PROCTER & GAMBLE (US) | 2025-03-26 | — | — | EP | disclosed |
| EP-3743035-B1 | METHOD OF FORMING MICROENCAPSULATED ACIDIC MATERIALS | ENCAPSYS LLC (US) | 2025-03-05 | — | — | EP | disclosed |
| US-20080118568-A1 | Benefit agent containing delivery particle | PROCTER & GAMBLE COMPANY, THE | 2008-05-22 | — | — | US | disclosed |
| US-20080014393-A1 | Functionalized substrates comprising perfume microcapsules | THE PROCTER & GAMBLE COMPANY | 2008-01-17 | — | — | US | disclosed |
| WO-2007099469-A2 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2007-09-07 | — | — | WO | disclosed |
| WO-2007100501-A2 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | APPLETON PAPERS INC. (US) | 2007-09-07 | — | — | WO | disclosed |
| US-20070202063-A1 | Benefit agent containing delivery particle | PROCTER & GAMBLE COMPANY, THE | 2007-08-30 | — | — | US | disclosed |
| US-20030232193-A1 | Dry film resist and printed circuit board producing method | FUJI PHOTO FILM CO., LTD. (JP) | 2003-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12558297-B2 | Consumer product with controlled release, biodegradable core-shell microcapsule compositions | LCT, CUTA, LIPE | TDP1 898/4885L3MBTL1 2302/4885CYP3A4 2470/4885 |
| US-20070202063-A1 | Benefit agent containing delivery particle | APOB, CHMP4B, HDLBP | TDP1 1276/4885L3MBTL1 2786/4885CYP3A4 4682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.